Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a well-differentiated high-grade neuroendocrine tumour, confirmed by a specialist pathologist who focuses on this type of cancer, with a specific cell growth rate marker (Ki-67) above 20% based on 2022 World Health Organization standards.
- People whose tumour started in the thymus, lung, or the duodenum-pancreas area.
- People who have advanced-stage tumour disease, with any number of previous treatments having been tried.
- People for whom sufficient medical records are available, including details about their diagnosis, treatments received, and health outcomes.
Who may not be able to join:
- People who have been diagnosed with a poorly differentiated neuroendocrine carcinoma, a lower-grade neuroendocrine tumour (G1 or G2) of the gut or pancreas, or a lung carcinoid tumour with a Ki-67 marker below 20% (confirm with trial site).
- People diagnosed with a mixed tumour type that contains both neuroendocrine and non-neuroendocrine cells (sometimes called MiNEN).
- People for whom there is not enough tumour tissue available, or tissue cannot be obtained, to carry out molecular testing.
- People whose medical records or follow-up information are incomplete.
- People whose tumour originated in a part of the body other than the lung or pancreas.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nicola Fazio, MD, IEO
Phone: 00390257489258
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Therapeutic algorithm
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.